DCGI

India yet to realise the full potential of digital health; crucial to develop models for their extension to rural India: DCGI – ET HealthWorld

by
India yet to realise the full potential of digital health; crucial to develop models for their extension to rural India: DCGI – ET HealthWorld

Mumbai: As digital technology is dominating the discourse of contemporary and future healthcare solutions, the Drugs Controller General of India (DGCI) has stressed that India is yet to fully realise that potential and it is crucial to develop models that ensure Digital Health solutions extend to rural India.” “Currently, most digital health solutions are concentrated … Read more

DCGI gives approval for Indian eye drops developed to reduce dependency on reading glasses

by
DCGI gives approval for Indian eye drops developed to reduce dependency on reading glasses

Image for representational purposes only. The Drugs Controller General of India (DCGI) has given its final approval for ENTOD Pharmaceuticals PresVu eye drops specifically developed to reduce dependency on reading glasses for individuals affected by presbyopia, a common age-related vision condition that typically impacts those over 40. The approval follows an earlier recommendation by the … Read more

Covid-19 vaccine: Covovax gets emergency nod for 12-18 age group

by
Covid-19 vaccine: Covovax gets emergency nod for 12-18 age group

The Novavax vaccine is manufactured and marketed in India by SII under the brand name, Covovax. The Drugs Controller General of India (DCGI) has granted emergency use authorisation (EUA) for the Novavax and Serum Institute of India (SII) Covid-19 vaccine, Covovax, in the 12-18 age group. Covovax is the fourth vaccine to receive EUA from … Read more

DCGI grants emergency use permission to single-dose Sputnik Light Covid vaccine

by
DCGI grants emergency use permission to single-dose Sputnik Light Covid vaccine

The firm presented that Sputnik Light vaccine is approved in 29 countries, including Russia and Argentina. The Drugs Controller General of India has granted emergency use permission to single-dose Sputnik Light Covid vaccine in the country, Union Health Minister Mansukh Mandaviya said on Sunday. This comes following recommendations of an expert panel of India’s central … Read more

India’s vaccination drive picks up for adults but long road ahead for children

by
India’s vaccination drive picks up for adults but long road ahead for children

Covaxin phase 2/3 studies have been completed for 2 to 17 years age group population and immunogenicity and safety data have been submitted to the Drugs Controller General of India (DCGI) for further approvals. Even as India’s cumulative Covid-19 vaccination coverage exceeds 75.89 Crore, Covid-19 vaccination of children with comorbidities in the 12 to 17 … Read more

DCGI directs bulk drugs manufacturers to submit applications online of already issued valid WCCs

by
DCGI directs bulk drugs manufacturers to submit applications online of already issued valid WCCs

Centre for Development of Advanced Computing (CDAC) in collaboration with Central Drugs Standard Control Organisation (CDSCO) has developed a module for online processing of applications for issuance of WCC as per the requirement of the European Union (EU). The Drugs Controller General of India (DCGI) has directed bulk drugs manufacturers to submit applications online of … Read more

Centre forms committee for framing new law for medicines, cosmetics, medical devices

by
Centre forms committee for framing new law for medicines, cosmetics, medical devices

The Drugs and Cosmetics (D&C) Act, 1940 regulates the import, manufacture, distribution and sale of drugs and cosmetics. The Union Health Ministry has formed a committee to frame the New Drugs, Cosmetics and Medical Devices Bill for the enactment of New Drugs, Cosmetics and Medical Devices Act. As per the terms of reference of the order … Read more

Hetero gets DCGI nod to launch biosimilar version of Tocilizumab

by
Hetero gets DCGI nod to launch biosimilar version of Tocilizumab

Hetero’s Tocilizumab 400mg/20ml is the biosimilar version of Roche’s Actemra/RoActemra drug. Tocilizumab is distributed by Cipla in India under licence from Roche. (Representational image) The Drug Controller General of India (DCGI) has granted Emergency Use Authorization (EUA) to Hetero for launching a biosimilar version of Tocilizumab, a Covid-19 drug for hospitalised adults. The Hyderabad-based company … Read more

Covid-19 Neutralizing Antibody Test critical for India’s fight against Coronavirus

by
Covid-19 Neutralizing Antibody Test critical for India’s fight against Coronavirus

WHO supports studies based on neutralizing antibody tests as they are critical for understanding infection’s extent and risk factors. By Jatin Mahajan, US Centre for Disease Control has recommended a 3rd dose of the Pfizer and Moderna Covid-19 vaccine for developing adequate antibodies amongst immunocompromised people. Some experts recommend a 3rd dose of Covishield six … Read more

Why rare diseases in India require robust government support to save patients’ lives

by
Why rare diseases in India require robust government support to save patients’ lives

Without any Government support for treatment, several patients have lost their lives in the interim. By Dr. Fauzia Khan Rare diseases affect only a small percentage of the populace in India or worldwide. The WHO definition uses the prevalence threshold as do most other countries, including India. This denotes a disease affecting less than one … Read more